Table 4

Summary of large reports of neonatal lenticulostriate vasculopathy (LSV)

Coley4 2000Chamnanvanakij7 2000Shefer-Kaufman2 1999Kriss8 1996Wang3 1995Cabanas5 1994Weber1 1992Hughes6 1991Teele9 1988This study 2002References 1–6 & Makhoul§
Some neonates had more than one diagnosis; cells without numbers indicate no available data.
*Includes respiratory distress syndrome, meconium aspiration syndrome, pneumonia, bronchopulmonary dysplasia.
†Includes cytomegalovirus (26), rubella (4), rotavirus (5).
‡Includes trisomy 13 (16), trisomy 21 (8), other (1).
§Reference 7 was not included because it included a selected population (premature infants <1250 g); references 8 and 9 were not included because the size of the study population was not recorded.
Number of infants1500193370058618933600132485713460
Number of head US1746427223204500953
LSV63 (4.2%)10 (5.1%)75 (2%)334 (5.8%)37 (1.95%)15 (0.4%)25 (1.9%)1221 (2.45%)270 (2%)
Gestational age (weeks)24–4128 (1.4)27–4328–4126–4028–4035–4035 (3.3)
Birth weight (g)2458 (1107)907 (224)880–45001075–4250900–43001400–37002351 (752)
Prematurity29 (46%)10 (100%)26 (35%)3 (8.8%)12 (32.4%)5 (33.3%)9 (36%)2 (16.6%)14 (66.6%)98 / 270 (36.3%)
Male/female ratio37/265/540/35018/199/610/154/812/9126/110
Asphyxia5004250016 / 140 (11.4%)
Respiratory disease*15503310830 / 161 (18.6%)
Congenital heart disease13001130018 / 140 (12.9%)
Viral infection†541065748129 / 270 (10.7%)
Chromosomal aberrations‡904331033020 / 270 (7.4%)
Fetal exposure (alcohol, drugs)40023010010 / 195 (5.1%)
Congenital malformations40301123525 / 140 (17.8%)
Mortality (%)15/63 (23.8%)3/3 (100%)4/37 (10.8%)6/12 (50%)019 / 121 (15.7%)